BOTHELL, Wash., April 30 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic monitoring devices (ECG, cardiac stress test, Holter, and cardiac rehabilitation) that connect to EMR and HIS systems, announced today that it will release its first quarter 2009 financial results on Thursday, May 7, 2009 after market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time. During the call, Cardiac Science management will discuss the financial results for the first quarter as well as the current business outlook.
To access the conference call, please dial 877.941.2333. International participants can dial 480.629.9723. The call will also be webcast live at www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at 800.406.7325 for U.S. callers or 303.590.3030 for those calling from outside the U.S. The password required to access the replay is 4064271#. An archived webcast will also be available at www.cardiacscience.com for 90 days.
For more information, Company Contact: Investor Contact: Media Contact: Mike Matysik Doug Sherk Christopher Gale Cardiac Science Corporation Jenifer Kirtland EVC Group, Inc. Sr. Vice President and CFO EVC Group, Inc. 646.201.5431 425.402.2009 415.896.6820 203.570.4681 firstname.lastname@example.org
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
|SOURCE Cardiac Science Corporation|
Copyright©2009 PR Newswire.
All rights reserved